BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37768152)

  • 21. Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma.
    Maciel J; Cavaco D; Silvestre C; Simões Pereira J; Vilar H; Leite V
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):814-821. PubMed ID: 35192239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recovery rate in differentiated thyroid cancer. Experiences of one of the Hungarian clinical centers].
    Szujó S; Bajnok L; Bódis B; Nemes O; Rucz K; Mezősi E
    Orv Hetil; 2018 Jun; 159(22):878-884. PubMed ID: 29806478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Follow-Up Strategy for Patients with an Excellent Response to Initial Therapy for Differentiated Thyroid Carcinoma: Less Is Better.
    Jeon MJ; Kim M; Park S; Oh HS; Kim TY; Kim WB; Shong YK; Kim WG
    Thyroid; 2018 Feb; 28(2):187-192. PubMed ID: 29179642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age, American Thyroid Association Risk Group, and Response to Therapy Are Prognostic Factors in Children With Differentiated Thyroid Cancer.
    Redlich A; Luster M; Lorenz K; Lessel L; Rohrer TR; Schmid KW; Frühwald MC; Vorwerk P; Kuhlen M
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e165-e177. PubMed ID: 34415989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic of recurrence and survival in poorly differentiated thyroid cancer.
    Hescot S; Al Ghuzlan A; Henry T; Sheikh-Alard H; Lamartina L; Borget I; Hadoux J; Baudin E; Dupuy C; Nikitski AV; Nikiforov YE; Schlumberger M; Nikiforova MN; Leboulleux S
    Endocr Relat Cancer; 2022 Nov; 29(11):625-634. PubMed ID: 36040800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical soft tissue recurrence of differentiated thyroid carcinoma after thyroidectomy indicates a poor prognosis.
    Gao L; Jiang Y; Liang Z; Zhang L; Mao X; Yang X; Wang Y; Xu J; Liu R; Zhu S; Zhao R; Lai X; Zhang X; Zhang B
    Int J Surg; 2017 Dec; 48():254-259. PubMed ID: 28919092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
    Stratmann M; Sekulla C; Dralle H; Brauckhoff M
    Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Recurrence Rates in a Cohort of Differentiated Thyroid Carcinoma Patients: A Referral Center Experience.
    Scheffel RS; Zanella AB; Antunes D; Dora JM; Maia AL
    Thyroid; 2015 Aug; 25(8):883-9. PubMed ID: 26061907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
    Lamartina L; Borget I; Mirghani H; Al Ghuzlan A; Berdelou A; Bidault F; Deandreis D; Baudin E; Travagli JP; Schlumberger M; Hartl DM; Leboulleux S
    J Clin Endocrinol Metab; 2017 Mar; 102(3):1020-1031. PubMed ID: 28359102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
    Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
    Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncological outcomes in differentiated thyroid cancer in South East Scotland.
    Sawant R; FitzGerald A; Hey SY; Hulse K; Hay A; Adamson R; Nixon IJ
    Surgeon; 2021 Dec; 19(6):e372-e378. PubMed ID: 33358594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients.
    Krajewska J; Jarząb M; Czarniecka A; Roskosz J; Kukulska A; Handkiewicz-Junak D; Puch Z; Wygoda Z; Paliczka-Cieślik E; Kropińska A; Gubała E; Jurecka-Lubieniecka B; Jarząb B
    Endokrynol Pol; 2016; 67(1):2-11. PubMed ID: 26884109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
    Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
    World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
    Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
    Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies.
    Adhikari LJ; Sciallis AP; Reynolds J; Jenkins S; Smith C; Stan MN; Nassar A
    Thyroid; 2013 Aug; 23(8):982-8. PubMed ID: 23374006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.